MXI1, the only prognostic marker among the studied genes [64], is a transcriptional repressor [83] and a tumour suppressor gene, because it acts as an antagonist of the oncogene c-Myc [84], which is overexpressed in many cases of prostate cancer. This evidence concerns the gene MYC and prostate cancer.